Document is current

Any future updates will be listed below

Retraction Note: Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial

Crossref DOI link: https://doi.org/10.1038/s41598-021-98683-5

Published Online: 2021-09-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark